CEACAM5
Basic information
Region (hg38): 19:41708585-41730433
Previous symbols: [ "CEA" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (78 variants)
- not_provided (13 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CEACAM5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004363.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | |||||
| missense | 72 | 85 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 72 | 8 | 11 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CEACAM5 | protein_coding | protein_coding | ENST00000221992 | 9 | 21215 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.16e-10 | 0.792 | 125691 | 0 | 56 | 125747 | 0.000223 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.186 | 370 | 380 | 0.973 | 0.0000210 | 4543 |
| Missense in Polyphen | 104 | 115.81 | 0.89802 | 1598 | ||
| Synonymous | -2.18 | 196 | 161 | 1.22 | 0.00000971 | 1449 |
| Loss of Function | 1.61 | 19 | 28.2 | 0.674 | 0.00000140 | 313 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000123 | 0.000123 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000648 | 0.0000615 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.00144 | 0.00144 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed:2803308, PubMed:10910050, PubMed:10864933). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed:10910050). {ECO:0000269|PubMed:10864933, ECO:0000269|PubMed:10910050, ECO:0000269|PubMed:2803308}.;
- Pathway
- Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins;Cell surface interactions at the vascular wall;Hemostasis
(Consensus)
Intolerance Scores
- loftool
- 0.746
- rvis_EVS
- 1.92
- rvis_percentile_EVS
- 97.44
Haploinsufficiency Scores
- pHI
- 0.0483
- hipred
- N
- hipred_score
- 0.194
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.250
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- apoptotic process;homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;negative regulation of myotube differentiation;homotypic cell-cell adhesion;negative regulation of apoptotic process;leukocyte migration;negative regulation of anoikis
- Cellular component
- extracellular region;plasma membrane;integral component of plasma membrane;cell surface;basolateral plasma membrane;apical plasma membrane;anchored component of membrane;extracellular exosome;integral component of external side of plasma membrane
- Molecular function
- GPI anchor binding;identical protein binding;protein homodimerization activity